Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis

Inclusion Criteria: * Primary axillary hyperhidrosis * Female or male, 18 years of age or older in good general health * Excessive sweating interferes with daily life activities and scores 3 or 4 on the HDSS at Screening and Baseline * Axillary sweat production of at least 50 mg/5 min measured gravimetrically Exclusion Criteria: * Any neurological condition, that may place the subject at increased risk with exposure to botulinum toxin type A such as amyotrophic lateral sclerosis and motor neuropathy, Lambert-Eaton syndrome, and Myasthenia gravis * Muscle weakness or paralysis, particularly in the upper extremities * Active skin disease or irritation or disrupted barrier at the treatment area * Undergone any procedures which may affect the axillary areas * Treatment with botulinum toxin type A in the axilla in the last 9 months or anywhere in the body in the last 6 months * Any prior axillary use of an anti-hyperhidrosis medical device * If menopausal had symptoms of menopause such as sweating or flushing within the last year